Simões, B. M., Pedley, R., McCloskey, C. W., Roberts, M., Reed, A. D., Twigger, A., Tharmapalan, P., Caruso, A., Cabral, S., Wilby, A. J., Harrison, H., Zhou, Y., Greenhalgh, A., Alghamdi, S. A., Forestiero, M., Lopez-Muñoz, J., Roche, J., Tuieng, R. J., Khan, M. A., Squires, S., Astley, S. M., Harkness, E. F., Santiago-Gómez, A., Spence, K., Ritchie, J., Pritchard, S., Lim, Y., Sherratt, M. J., Andò, S., Howell, A., Evans, D. G., Gilmore, A. P., Khaled, W. T., Khokha, R., Clarke, R. B., Howell, S. J. (2025). Anti-progestin therapy targets hallmarks of breast cancer risk. Nature. https://doi.org/10.1038/s41586-025-09684-7